Nordic Psychedelic Science Conference 2022

Showcasing current research on psychedelics, and creating a Nordic network of relevant actors in the field

Nordic researchers are currently participating in international trials using MDMA for the treatment of PTSD, and psilocybin and ketamine for the treatment of depression. Psychedelics are increasingly prominent in the fields of basic science and social science. The Nordic Psychedelic Science Conference (NPSC) mission was to put the Nordic countries on the map of global psychedelic research and in order to achieve that goal we saw a need to build a foundation for an organized scientific field by showcasing current research and creating a nordic network of relevant actors. Based on the feedback from participants, speakers and partners, we believe NPSC 2022 was a success and a great first edition to what we aspire to make a bi-annual event.

The conference took place at the beautiful House of Design and Architecture (DOGA) in Oslo on the 19th and 20th of May 2022. The program was split into two parts; the first part was a two day academic program tailored for researchers, healthcare professionals, and students; the second part was an evening symposium organized to be accessible to the wider public. The academic conference hosted 204 participants, while the symposium hosted 323 participants. There were in total 27 speakers and panel participants on stage, as well as two psychedelic-assisted therapy patients offering their experience and a musical performance by the Norwegian artist Niilas. Lectures from the conference are available on the conference Youtube channel.